Biotech Pitch Deck Narrative

Overview

Strategic communication tool that translates complex biotechnology innovations into compelling business narratives optimized for venture capital, pharmaceutical partnerships, and public market investors.

Key Capabilities:

• Science Translation: Convert technical data into business value language
• Narrative Architecture: Structure Problem→Solution→Market→Traction→Vision flow
• Stage Optimization: Tailor messaging for seed through IPO fundraising
• Investor Calibration: Adapt for generalist vs. specialist audiences
• Risk Mitigation: Frame scientific and regulatory risks as manageable challenges
• Q&A Preparation: Anticipate investor questions and prepare responses

When to Use

✅ Use this skill when:

• Preparing Series A/B pitch decks for VC presentations
• Creating management presentations for IPO roadshows
• Developing BD materials for pharma partnership discussions
• Crafting executive summaries for grant applications
• Rehearsing investor Q&A for earnings calls
• Translating clinical data into commercial narratives
• Adapting academic presentations for business audiences

❌ Do NOT use when:

• Scientific conference presentations → Use technical language
• Regulatory submission documents → Use formal FDA/EMA formats
• Internal R&D team communications → Use full scientific detail
• Patent applications → Use precise legal/scientific terminology
• Patient-facing materials → Use lay-summary-gen

Integration:

• Upstream: market-access-value (commercial assessment), competitor-trial-monitor (competitive landscape)
• Downstream: business-model-canvas (strategy development), investor-relations-prep (ongoing communications)

Core Capabilities

1. Science-to-Business Translation

Convert technical concepts into investor-friendly language:

from scripts.narrative_engine import BiotechNarrativeEngine

engine = BiotechNarrativeEngine()

# Translate technical description
translation = engine.translate_science(
    technical_description="""
    Our proprietary AAV9-based gene therapy utilizes a codon-optimized 
    transgene under control of a liver-specific promoter to restore 
    functional enzyme in patients with MPS I deficiency.
    """,
    audience="generalist_vc",
    preserve_accuracy=True
)

print(translation.business_narrative)
# "One-time gene therapy delivering a functional copy of the missing enzyme, 
#  potentially curing MPS I rather than managing symptoms"